Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $669,027 - $854,286
-1,904 Closed
0 $0
Q3 2021

Oct 12, 2021

SELL
$372.64 - $458.3 $101,358 - $124,657
-272 Reduced 12.5%
1,904 $786,000
Q2 2021

Aug 09, 2021

BUY
$294.17 - $371.65 $37,653 - $47,571
128 Added 6.25%
2,176 $805,000
Q1 2021

May 10, 2021

BUY
$249.67 - $299.48 $511,324 - $613,335
2,048 New
2,048 $594,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.